Studies related to Sperm Count and Astaxanthin

Combined Conventional/antioxidant "Astaxanthin" Treatment For Male Infertility: A Double Blind, Randomized Trial

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 30
Sex Male
Age Range 18-29, 30-44
Notes for this study:
In infertile men given 16mg of astaxanthin daily for three months noted reductions in serum Inhibin B (29%) and improvements in seminal reactive oxygen species content (to 25% of baseline) although no other sperm parameter such as count of morphology was affected. Pregnancy rates increased with supplementation relative to placebo, possibly related to significant improvements in sperm adherence to oocytes.
Funding issues for this study:
Funded by the producers of the astaxanthin product, AstaReal